Fabio Iwamoto, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nivolumab for Recurrent or Progressive IDH Mutant Gliomas (NCT03557359) | Fabio Iwamoto, MD | 2018-06-12 |
Track Fabio Iwamoto, MD automatically
Every clearance here is in the API, with alerts when new ones post.